Featured Article

Fasenra is a prescription pen-injectable medication used for the treatment of severe asthma in patients aged 12 and older. The medication is a biologic drug, making it a unique form of asthma treatment.

Fasenra is an injectable medication that can be self-administered through a pen-style device. Its portability allows the participant to self-administer from any location, making the medication more available and convenient when needed.

The benefits of Fasenra include improved lung function, reduced exacerbations and asthma-related hospitalizations, improved quality of life, and a decreased reliance on other asthma medications. Fasenra works specifically by targeting an interleukin-5 (IL-5) cytokine receptor found on eosinophils, which are cells that play an important role in severe asthma, helping to decrease their number and improve the participant’s overall health.

Fasenra relieves a number of asthma symptoms, such as coughing, wheezing, and shortness of breath. Additionally, it aids in reducing the amount of systemic corticosteroid medication needed to control asthma symptoms, and can be combined with other medications, such as the